✦ LIBER ✦

The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes

✍ Scribed by G. Tricot; M. A. Boogaerts

Book ID: 114710921
Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 404 KB
Volume: 63
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1986.tb07524.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of low-dose cytosine arabinosid

The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes

✍ Carlo Aul; Wolfgang Schneider 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

The role of low-dose chemotherapy in mye

The role of low-dose chemotherapy in myelodysplastic syndromes

✍ Carlo Aul; Norbert Gattermann 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 893 KB

The role of decitabine in the treatment

The role of decitabine in the treatment of myelodysplastic syndromes

✍ Atallah, Ehab; Kantarjian, Hagop; Garcia-Manero, Guillermo 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 177 KB

Role of Lenalidomide in the Treatment of

Role of Lenalidomide in the Treatment of Myelodysplastic Syndromes

✍ Rami S. Komrokji; Alan F. List 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 876 KB

The treatment of the myelodysplastic syn

The treatment of the myelodysplastic syndromes

✍ Harvey D. Preisler 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

T he article by Ferrara et al. 1 in this issue of Cancer describes the treatment of patients with poor prognosis myelodysplastic syndromes (MDS) using intensive remission induction chemotherapy followed by peripheral blood stem cell transplantation for patients age Ͻ 60 years. Thirty-two patients wi

Standard and low-dose chemotherapy for t

Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes

✍ Bruce D Cheson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 64 KB